Research never stops

Top Story

Evotec and APEIRON achieve first milestone in immuno-oncology alliance with Sanofi

Hamburg, Germany and Vienna, Austria, 08 January 2018:
Evotec AG and APEIRON Biologics AG, a company focused on cancer immunotherapy, announced today that the companies received the first milestone payment

- read more

Evotec enters into research collaboration with CRTD to discover novel therapies for retinal diseases

Dresden and Hamburg, Germany, 13 December 2017: Evotec AG today announced that it has entered into a research collaboration with the Center for Regenerative Therapies TU Dresden ("CRTD") to discover novel small molecule candidates for retinal diseases.

- read more

Evotec to attend upcoming investor conferences

Hamburg, Germany, 03 January 2018:
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its management will be presenting

- read more
loading weather report
Loading weather report...


Feb 01, 2018 - German Equity Forum

Company Presentation January

Building integrated and high-value drug discovery alliances
2018-01_Evotec_Company presentation_January